Kasan Insight :: Korea IP Law Blog

1. Permanent Injunction The nature of a patent right is the right to exclude others. Once the patent has been held valid and infring...

The rationales of the doctrine of equivalents in Korea are basically similar to those of the U.S. Namely, when an accused product or process...

Under the Korean patent law, when there are joint inventors of a single invention, each inventor is entitled to be a joint owner in the righ...

Based on 12 months grace period under the Korean patent law, an inventor or his assignee may obtain a patent through filing an application f...

The number of patent applications in Korea has steadily increased in 5 recent years. According to statistics from KIPO, the number of patent...

1. An applicant may file an English specification without the Korean translation An applicant may file a provisional application in ...

Trade secret Infringers may be prosecuted as criminals in addition to civil litigations. The Korean UCPA stipulates that anyone who illegall...

1. Initiation of Investigation Investigation is initiated upon discovery of the possibility that a crime may have been committed. The ult...

1. What is Trade Secret under Korean law? “Trade secret” under Article 2.2 of the UCPA of Korea means technical or business informa...

Statistics of KIPO - IP Applications Trend Over Three Years in Korea

Article 30 of the Korean Patent Act provides 12 months grace period for disclosed inventions. In inventor or his assignee may obtain a pate...

Remicade is a monoclonal antibody to treat RA. This blockbuster biopharmaceutical product was developed and has been sold by Centocor that ...

KIPO published the annual report of 2013 that includes statistics of filing numbers. In 2013, KIPO received 204,589 new patent applicat...

1. Background GSK owned a Korean patent for ondansetron, antiemetic drug and sold with a tradename as Zofran. Dong-A Pharmaceutical ...

The FTA between Korea and USA includes provisions regarding the patent drug market approval (MA) linkage. Pursuant to the KORUS FTA, Korea h...

Korea becomes one of the largest pools of patent publications in the world. In every year, KIPO receives over 350,000 domestic patent appli...

In 2011, KIPO received about 180,000 patent applications. Among them, 23%, 40,890 Korean patent applications were filed by foreign applica...

In general, a claim with functional language is very often objected by the Examiner in Korean patent practice. Examiners usually consider f...

Novartis' Exelon® Patch has been used to treat mild to moderate dementia of the Alzheimer's type and mild to moderate dementia assoc...

In general, the specification for a new chemical compound should describe physicochemical data of the claimed compound to such an extent th...